Perspective Therapeutics

Perspective senior management will participate in two investor conferences in April. Check our newsroom for more details -> perspectivetherapeutics.com/pr/perspective…

This #WorldTheranosticsDay, we’re highlighting how #theranostics combines diagnostics and treatment to guide better decisions and improve outcomes. Perspective is advancing a platform pairing imaging with targeted therapy to support more personalized care: perspectivetherapeutics.com/technology/the…

Updated data from our [212Pb]VMT-α-NET program have been accepted as a poster presentation at #AACR26 titled, “[212Pb]VMT-a-NET in advanced SSTR2+ neuroendocrine tumors: safety and preliminary efficacy results from dose-finding cohorts 1, 2 and 3”. perspectivetherapeutics.com/pr/perspective…

Perspective provided recent business highlights and reported FY25 results. We shared clinical updates on [212Pb]VMT-α-NET at #GI26, and we continue to advance our pipeline of targeted #radiopharmaceuticals. For more: perspectivetherapeutics.com/pr/perspective…

Perspective will be participating in a fireside chat tomorrow at the Barclays 28th Annual Global Healthcare Conference in Miami, FL today from 11-11:25 a.m. ET. Check our events page for more details -> perspectivetherapeutics.com/investors/even…

Next Monday, Perspective will be participating in 1x1s only at the UBS Biotech Summit Miami – Catalyst for Change. Check our events page for more details -> perspectivetherapeutics.com/investors/even…

Perspective will be presenting at the TD Cowen 46th Annual Health Care Conference in Boston, MA today from 3:10–3:40 p.m. ET. Check our events page for more details -> perspectivetherapeutics.com/investors/even…

Thank you to Oscar Wu of @GeneOnline for including $CATX in this overview of the #radiopharma sector’s trajectory. The two defining themes: the move toward more potent alpha emitters and the importance of secure, scalable isotope supply chains. Read here: geneonline.com/illustrations-…

#ICYMI – At @ASCO #GI26, we presented updated interim data for [212Pb]VMT-α-NET in patients with advanced SSTR2+ NETs. See @TargetedOnc overview here: targetedonc.com/view/antitumor…

Our CEO, Thijs Spoor, was recently featured on The BioHub podcast with Max Brennan, discussing our company vision for targeted #radiopharmaceuticals and the milestones that could shape our next phase of growth. Listen here: podcasts.apple.com/us/podcast/epi… open.spotify.com/episode/6EzLcg…

Save the date! Perspective Therapeutics to provide recent business highlights and report FY25 financial results on Monday, March 16: perspectivetherapeutics.com/pr/perspective…

We’re pleased to share that on Wednesday, our SVP, Global Regulatory Affairs, Belén Carrillo-Rivas, D.Phil, will be moderating a panel discussion, “Financing STEM for Inclusive Growth and Sustainable Development,” at the @UN in NYC. For more details: un.org/en/observances…

On #WorldCancerDay, we recognize patients, families, caregivers, clinicians, and researchers impacted by #cancer. Perspective reaffirms our commitment to improving outcomes for those living with cancer by amplifying @UICC's #UnitedByUnique campaign: worldcancerday.org/the-campaign

At the Sachs Oncology Forum ahead of #JPM26, our CEO, Thijs Spoor, joined fellow #radiopharmaceutical leaders to discuss why #radioligand therapies may be approaching a major inflection point. Read the article by Jonah Comstock of @Pharmaphorum here: bit.ly/3NObKqW

Our CEO, Thijs Spoor, recently joined @FiercePharma's Fraiser Kansteiner on “The Top Line” podcast alongside several other biopharma CEOs to reflect on what defined 2025 and what's to come in 2026. Listen to the discussion here: bit.ly/4qk1UeT

Our CEO, Thijs Spoor, was featured in a recent @FiercePharma roundtable with Fraiser Kansteiner, highlighting renewed momentum in #biotech investment, the importance of manufacturing, and why 2026 could be a pivotal year for #radiopharma. Read here: bit.ly/4jF2KjN

Perspective has announced business updates and strategic priorities for the next 12-18 months and will present updates at the 44th Annual J.P. Morgan Healthcare Conference tomorrow at 2:15pm PT. #JPM26 $CATX For more details: perspectivetherapeutics.com/pr/perspective…

We’re pleased to share that CEO Thijs Spoor will be presenting at #JPM2026 in San Francisco. The company presentation will take place on Wednesday, January 14, from 2:15–2:55pm PT, at The Westin St. Francis Hotel. $CATX For more details: perspectivetherapeutics.com/pr/perspective…

CEO Thijs Spoor will be moderating a panel discussion tomorrow at the 9th Annual BFC Global Healthcare BD & Investment Conference in SF. The panel, “From Asia to the World – Redefining Global Pharma Collaboration,” will take place from 10:15-11:15 am PT: 2026sf.bfcconference.com

CEO Thijs Spoor will be participating in the “Advancing Next-Gen Targeted Radiopharmaceuticals in Oncology” panel discussion this Saturday, at the 11th Annual Oncology Innovation Forum for Business Development, Licensing & Investment in SF. $CATX sachsforum.com/11oif-about.ht…